(Q48029634)
Statements
Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000) (English)
Elisabeth Wassner-Fritsch
Franck Morschhauser
Robert Marcus
Michael Wenger
scientific article published on 10 July 2013
No description defined